These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 28873303)
21. Resveratrol and curcumin synergistically induces apoptosis in cigarette smoke condensate transformed breast epithelial cells through a p21(Waf1/Cip1) mediated inhibition of Hh-Gli signaling. Mohapatra P; Satapathy SR; Siddharth S; Das D; Nayak A; Kundu CN Int J Biochem Cell Biol; 2015 Sep; 66():75-84. PubMed ID: 26212257 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of SANT-2 and analogues as inhibitors of the hedgehog signaling pathway. Büttner A; Seifert K; Cottin T; Sarli V; Tzagkaroulaki L; Scholz S; Giannis A Bioorg Med Chem; 2009 Jul; 17(14):4943-54. PubMed ID: 19541490 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and evaluation of third generation vitamin D3 analogues as inhibitors of Hedgehog signaling. Maschinot CA; Chau LQ; Wechsler-Reya RJ; Hadden MK Eur J Med Chem; 2019 Jan; 162():495-506. PubMed ID: 30471551 [TBL] [Abstract][Full Text] [Related]
24. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo. Wickström M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevåg OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI Int J Cancer; 2013 Apr; 132(7):1516-24. PubMed ID: 22949014 [TBL] [Abstract][Full Text] [Related]
25. Protein kinase C-delta and mitogen-activated protein/extracellular signal-regulated kinase-1 control GLI activation in hedgehog signaling. Riobo NA; Haines GM; Emerson CP Cancer Res; 2006 Jan; 66(2):839-45. PubMed ID: 16424016 [TBL] [Abstract][Full Text] [Related]
26. Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors. Infante P; Mori M; Alfonsi R; Ghirga F; Aiello F; Toscano S; Ingallina C; Siler M; Cucchi D; Po A; Miele E; D'Amico D; Canettieri G; De Smaele E; Ferretti E; Screpanti I; Uccello Barretta G; Botta M; Botta B; Gulino A; Di Marcotullio L EMBO J; 2015 Jan; 34(2):200-17. PubMed ID: 25476449 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of WO2014207069 A1: Multitarget Hedgehog pathway inhibitors and uses thereof. Manetti F; Petricci E Expert Opin Ther Pat; 2016; 26(4):529-35. PubMed ID: 26666870 [TBL] [Abstract][Full Text] [Related]
28. Nanoquinacrine induced apoptosis in cervical cancer stem cells through the inhibition of hedgehog-GLI1 cascade: Role of GLI-1. Nayak A; Satapathy SR; Das D; Siddharth S; Tripathi N; Bharatam PV; Kundu C Sci Rep; 2016 Feb; 6():20600. PubMed ID: 26846872 [TBL] [Abstract][Full Text] [Related]
30. Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors. Arnhold V; Boos J; Lanvers-Kaminsky C Cancer Chemother Pharmacol; 2016 Mar; 77(3):495-505. PubMed ID: 26781311 [TBL] [Abstract][Full Text] [Related]
31. Berberine, a natural compound, suppresses Hedgehog signaling pathway activity and cancer growth. Wang J; Peng Y; Liu Y; Yang J; Ding N; Tan W BMC Cancer; 2015 Aug; 15():595. PubMed ID: 26296751 [TBL] [Abstract][Full Text] [Related]
32. Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma. Infante P; Malfanti A; Quaglio D; Balducci S; De Martin S; Bufalieri F; Mastrotto F; Basili I; Garofalo M; Lospinoso Severini L; Mori M; Manni I; Moretti M; Nicoletti C; Piaggio G; Caliceti P; Botta B; Ghirga F; Salmaso S; Di Marcotullio L Cancer Lett; 2021 Feb; 499():220-231. PubMed ID: 33249196 [TBL] [Abstract][Full Text] [Related]
34. L-4, a Well-Tolerated and Orally Active Inhibitor of Hedgehog Pathway, Exhibited Potent Anti-tumor Effects Against Medulloblastoma Zhu M; Wang H; Wang C; Fang Y; Zhu T; Zhao W; Dong X; Zhang X Front Pharmacol; 2019; 10():89. PubMed ID: 30846937 [TBL] [Abstract][Full Text] [Related]
35. AT-101 inhibits hedgehog pathway activity and cancer growth. Wang J; Peng Y; Liu Y; Yang J; Huang M; Tan W Cancer Chemother Pharmacol; 2015 Sep; 76(3):461-9. PubMed ID: 26113054 [TBL] [Abstract][Full Text] [Related]
36. Cilia and Hedgehog responsiveness in the mouse. Huangfu D; Anderson KV Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11325-30. PubMed ID: 16061793 [TBL] [Abstract][Full Text] [Related]
37. Inhibition mechanism exploration of investigational drug TAK-441 as inhibitor against Vismodegib-resistant Smoothened mutant. Ishii T; Shimizu Y; Nakashima K; Kondo S; Ogawa K; Sasaki S; Matsui H Eur J Pharmacol; 2014 Jan; 723():305-13. PubMed ID: 24291104 [TBL] [Abstract][Full Text] [Related]
38. MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor. Hoch L; Faure H; Roudaut H; Schoenfelder A; Mann A; Girard N; Bihannic L; Ayrault O; Petricci E; Taddei M; Rognan D; Ruat M FASEB J; 2015 May; 29(5):1817-29. PubMed ID: 25636740 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Lauth M; Bergström A; Shimokawa T; Toftgård R Proc Natl Acad Sci U S A; 2007 May; 104(20):8455-60. PubMed ID: 17494766 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic and pharmacodynamic modeling of hedgehog inhibitor TAK-441 for the inhibition of Gli1 messenger RNA expression and antitumor efficacy in xenografted tumor model mice. Kogame A; Tagawa Y; Shibata S; Tojo H; Miyamoto M; Tohyama K; Kondo T; Prakash S; Shyu WC; Asahi S Drug Metab Dispos; 2013 Apr; 41(4):727-34. PubMed ID: 23298863 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]